Showing 36,902 results

Filters
Access to healthcare

EECA CAB positions in regards to Janssen, BMS, Gilead and ViiV policy

Editor's pick
EATG
9 March 2015
PrEP

UNAIDS welcomes further evidence of the efficacy of antiretroviral medicines in preventing new HIV infections

Editor's pick
UNAIDS
27 February 2015
New & experimental HIV treatments

48-week analysis of investigational HIV-1 attachment inhibitor paves way for Phase III trial initiation

Editor's pick
Bristol Myers Squibb press release
26 February 2015
PrEP

HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

Editor's pick
EATG
25 February 2015
The search for a cure

New clues about viral rebound in Mississippi child thought cured of HIV

Editor's pick
HIVandHepatitis.com
23 February 2015
Access to healthcare

UNITAID: 2015 Hepatitis C medicines technology and market landscape

Editor's pick
UNITAID
13 February 2015
Access to healthcare

Portugal agrees to treat 13,000 hepatitis C patients

Editor's pick
Xinhua
9 February 2015
Pharmaceutical industry

AbbVie Inc stock drops after expectations for Viekira Pak fall short

Editor's pick
Bidness Etc
2 February 2015
Access to healthcare

Petition: Equitable access to HCV drugs

Editor's pick
Petitionbuzz
30 January 2015
Health problems & ageing

Herpes zoster incidence higher among patients with HIV

Editor's pick
Healio
30 January 2015
New & experimental HIV treatments

PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Editor's pick
Janssen press release
30 January 2015
New & experimental HIV treatments

U.S. Food and Drug Administration approves Bristol-Myers Squibb’s Evotaz™ (atazanavir and cobicistat) for the treatment of HIV-1 infection in adults

Editor's pick
Bristol-Myers Squibb press release
30 January 2015
Access to healthcare

Russia may face shortage of anti-AIDS drugs in 2015

Editor's pick
EATG
29 January 2015
Access to healthcare

MSF response to Gilead announcement on inclusion of hepatitis C drug GS-5816 in voluntary licence

Editor's pick
Médecins Sans Frontières press release
27 January 2015
Access to healthcare

Ahead of Obama visit, MSF warns US pressure on India could impact access to medicines for millions

Editor's pick
Medecins Sans Frontieres press release
23 January 2015
Cancer

Low CD4 count, suboptimal HIV treatment linked to higher anal cancer risk

Editor's pick
HIVandHepatitis.com
23 January 2015
Hepatitis C treatment

Merck discontinues Victrelis (boceprevir) voluntarily in the United States

Editor's pick
EATG
21 January 2015
New & experimental HIV treatments

New anti HIV drug dolutegravir is effective at low doses

Editor's pick
MMD Newswire
21 January 2015
Hepatitis C transmission & prevention

Vertical transmission of HCV: The next big treatment frontier

Editor's pick
EATG
20 January 2015
Hepatitis C symptoms & diagnosis

UNITAID publishes comprehensive review of detection and monitoring technologies for hepatitis C

Editor's pick
UNITAID press release
20 January 2015
Hepatitis C treatment

US: Prime Therapeutics breaks from competition, strikes deals to prefer both Harvoni, Viekira hepatitis C drugs

Editor's pick
Prime Therapeutics press release
13 January 2015
New & experimental hepatitis C treatment

Merck speeds up drug-submission plans for hep C, lung cancer

Editor's pick
Reuters
13 January 2015
PrEP

PrEP works in women using injectable hormonal contraceptives and in their male sex partners

Editor's pick
International AIDS Society
7 January 2015
PrEP

Tenofovir-based HIV PrEP does not harm kidneys

Editor's pick
Medscape (requires free registration)
26 December 2014